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Mammalian photoreceptors contain specialised connecting cilia that connect the inner (IS) to the outer
segments (OS). Dysfunction of the connecting cilia due to mutations in ciliary proteins are a common
cause of the inherited retinal dystrophy retinitis pigmentosa (RP). Mutations affecting the Retinitis
Pigmentosa GTPase Regulator (RPGR) protein is one such cause, affecting 10e20% of all people with RP
and the majority of those with X-linked RP. RPGR is located in photoreceptor connecting cilia. It interacts
with a wide variety of ciliary proteins, but its exact function is unknown. Recently, there have been
important advances both in our understanding of RPGR function and towards the development of a
therapy. This review summarises the existing literature on human RPGR function and dysfunction, and
suggests that RPGR plays a role in the function of the ciliary gate, which controls access of both mem-
brane and soluble proteins to the photoreceptor outer segment. We discuss key models used to inves-
tigate and treat RPGR disease and suggest that gene augmentation therapy offers a realistic therapeutic
approach, although important questions still remain to be answered, while cell replacement therapy
based on retinal progenitor cells represents a more distant prospect.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Photoreceptor degeneration is the hallmark of retinitis pig-
mentosa (RP), an inherited retinal dystrophy affecting 1 in 3000
people that commonly causes severe visual loss and blindness in
middle life (Bramall et al., 2010; Wright et al., 2010; Sahel et al.,
2014). Mutations in over 50 genes are now known to cause RP,
which can be inherited as an autosomal dominant, autosomal
recessive, X-linked or mitochondrial trait (https://sph.uth.edu/
retnet/). There are syndromal and non-syndromal forms of RP
and digenic forms have also been described (Kajiwara et al., 1994).
Mutations in the RPGR gene account for 70e90% of the X-linked
form of RP (XLRP) and 10e20% of all RP. Mutations in the RP2 gene
account for most of the remaining ~20% of XLRP. XLRP is associated
with a severe phenotypewith marked rod and later cone cell death,
extinguished rod electroretinogram and visual loss, commonly
starting within the ﬁrst few decades of life. At present, there is noaw), Dinesh.Soares@ed.ac.uk
t).
r Ltd. This is an open access articletreatment for disease caused by RPGR mutations (“RPGR disease”).
However, an improved understanding of the protein's function has
emerged in parallel with the emergence of novel technologies to
model or potentially treat RPGR disease. Recent gene augmentation
therapy successes using animal models have brought renewed
hope for those affected by this debilitating illness (Bainbridge et al.,
2008; Beltran et al., 2012).2. RPGR structure and function
The RPGR gene is located on the short arm of the X chromosome
(Xp21.1) (Meindl et al., 1996; Vervoort et al., 2000) and expresses at
least 10 alternative transcripts of which 5 are predicted to be pro-
tein coding (Kirschner et al., 1999; Roepman et al., 2000; Neidhardt
et al., 2007; Schmid et al., 2010). Expression of the major splice
variants (see below) is at least partly driven by a TATA-less proximal
promoter (Shu et al., 2012), which ﬁts with the widespread
expression of RPGR in adult mammalian tissues. The promoter
contains 4 transcriptional start sites which may inﬂuence expres-
sion in different tissues and within which the transcription factor
SP1 was shown to activate RPGR transcription. The protein productsunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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extensively studied (Fig. 1a) (Meindl et al., 1996; Roepman et al.,
1996; Vervoort et al., 2000; Mavlyutov et al., 2002; Hong et al.,
2003; Patil et al., 2012a).
The ﬁrst transcript to be identiﬁed was the ‘constitutive’
RPGREx1-19 isoform which is widely expressed in tissues (Meindl
et al., 1996; Roepman et al., 1996; Vervoort et al., 2000) and is
found within cells at the transition zone of primary and motile cilia
(Hong et al., 2003; Iannaccone et al., 2003) or at centrosomes and
their constituent centrioles in dividing cells. In the retina, the
RPGREx1-19 isoform localises to the developing and mature photo-
receptor connecting cilium (CC), connecting the inner and outer
segments, but shows a slightly different developmental expression
pattern and afﬁnity for the axonemal (detergent insoluble) fraction
compared with the other major RPGR isoform (RPGRORF15), sug-
gesting overlapping but also distinct functions (Wright et al., 2011).
The RPGREx1-19 transcript encodes a predicted 90 kDa protein with
19 exons of the gene transcribed. Exons 1 to 10 of RPGREx1-19 encode
an RCC1-like domain (Meindl et al., 1996; W€atzlich et al., 2013) and
the C-terminus has an isoprenylation motif (CAAX), suggesting that
this isoform is membrane bound, consistent with its reported
attachment to endoplasmic reticulummembranes in addition to its
presence at CC (Patil et al., 2012a). Yan et al. (1998) suggested a
Golgi localisation for RPGR but this has not been conﬁrmed (Patil
et al., 2012a). No disease-causing mutations have been reported
in exons 16 to 19. In contrast, all known mutations causing XLRP or
related retinal dystrophies are found to affect the RPGRORF15Fig. 1. Major RPGR protein isoforms (constitutive RPGREx1-19 and RPGRORF15) domain schem
scale. The seven blades (B1 to B7) that form the beta-propeller RCC1-like domain (RLD) enco
isoprenylation site (CAAX) is shown. The location of the RPGRORF15 Glutamate/Glycine-rich
known disease-causing missense mutations (labelled), and a total of 52 known nonsense mu
schematic) are indicated. Mutation data was mapped from the Human Gene Mutation Data
RPGR RLD (blue) in complex with PDEd (yellow) (W€atzlich et al., 2013) and RPGRIP1 (gre
representations with a transparency setting to highlight location of known missense muta
interaction sites on the surface RPGR partially overlap (Remans et al., 2014).isoform (Fig. 1a), which shows highest expression in the retina
(Vervoort et al., 2000; Hong et al., 2003; Mavlyutov et al., 2002;
Patil et al., 2012b; Iannaccone et al., 2003).
The human RPGRORF15 transcript encodes a 1152 amino acid
protein consisting of exons 1 to 14 of RPGREx1-19 followed by a
unique C-terminal exon called ORF15, encoding 567 amino acids
(Vervoort et al., 2000). Exon ORF15 is formed by exon 15 extending
into intron 15 due to skipping of the splice donor site for exon 15
(Vervoort et al., 2000). The RPGRORF15 isoform is predicted to be
127 kDa and exon ORF15 includes an acidic, repetitive, glutamic
acid/glycine-rich domain and a basic C-terminal domain (Fig. 1a).
The repetitive domain length is not under strict evolutionary
constraint, varying considerably among species and across strains
of mice and a partial truncation of murine ORF15 does not appear to
alter its function (Vervoort et al., 2000; Hong et al., 2005). In
contrast, the basic C-terminal domain is highly conserved among
vertebrates (Shu et al., 2005). RPGRORF15 is most strongly expressed
in retina (Vervoort et al., 2000) where its protein product is local-
ised to the photoreceptor CC (Hong et al., 2000, 2003; Mavlyutov
et al., 2002). There is uncertainty as to whether or not RPGRORF15
is present in the OS. Discrepancies between laboratories may be
due to different antibodies, tissue processing procedures or species
differences in OS structure (Mavlyutov et al., 2002; Shu et al., 2006).
For example, it may depend on whether OS have multiple super-
ﬁcial incisures (as in humans and amphibia) or single deep inci-
sures (as in rodent, bovine, canine OS) (Mavlyutov et al., 2002).
However, while some antibodies clearly label human OS (Roepmanatic. (a) Domain architecture schematics for both major isoforms are shown drawn to
ded within Exons 1e10 in both major isoforms are indicated. The RPGREx1-19 C-terminal
Domain and Basic Domain (BD) within the Open Reading Frame 15 are highlighted. All
tations speciﬁcally located within the Open Reading Frame 15 (vertical lines on domain
base (Stenson et al., 2014) (accessed 27th May 2015). (b) The crystal structures of the
en) (Remans et al., 2014) are shown using PyMol (http://www.pymol.org) as surface
tions (red spheres, only alpha carbon atoms shown) on structure. PDEd and RPGRIP1
R.D. Megaw et al. / Experimental Eye Research 138 (2015) 32e4134et al., 2000; Iannaccone et al., 2003; Mavlyutov et al., 2002), this is
not the case in rodents or pigs (Hong et al., 2003; Brunner et al.,
2010; Wright et al., 2012) and the situation in bovine OS is un-
clear (Hong et al., 2003; Mavlyutov et al., 2002; Beltran et al., 2012).
In dividing cells, RPGRORF15 is present in centrosomes, while in non-
dividing cells containing primary cilia it is found in the transition
zone of the ciliary axoneme, the equivalent structure to the
photoreceptor CC (Hong et al., 2003; Shu et al., 2005; Gakovic et al.,
2011).
The exon ORF15 repetitive domain is a mutational hotspot for
XLRP, accounting for two-thirds of all disease-causing mutations
(Vervoort et al., 2000; Sharon et al., 2003) (Fig. 1a). Most ORF15
mutations are out-of-frame deletions of 1e5 bp that are predicted
to produce truncated proteins with novel amino acid sequences
and often a change from an acidic to a basic net charge (Wright and
Shu, 2007). The basic C-terminal domain is predicted to be trun-
cated or lost with most ORF15 mutations, which, in general, are
associated with slightly milder disease than with mutations
occurring in the N-terminal RCC1-like domain (Sharon et al., 2003).
Indeed, the closer that exon ORF15 mutations are to the 30 end, the
less severe the phenotype. Mutations within a C-terminal exon,
such as ORF15, are not expected to result in nonsense-mediated
decay of the transcript so the presence of truncated, potentially
gain-of-function, mutant proteins could exacerbate the loss of
function due to premature stop codons (Fahim et al., 2011; Hong
et al., 2004). This possibility is supported by the more severe
phenotype accompanying a naturally occurring ORF15 mutation in
XLPRA2 dogs which leads to an abnormally charged and novel C-
terminus compared with an immediate truncation with the milder
XLPRA1 phenotype in progressive retinal atrophy (PRA) dogs (Zeiss
et al., 1999; Zhang et al., 2002). However, it is also possible that the
XLPRA1 mutation is hypomorphic and the XLPRA2 mutation is null
(Beltran et al., 2014).
3. RPGR in development
Analyses of RPGR knockout (KO) mice showed that RPGR is not
essential for mammalian photoreceptor development (Hong et al.,
2000). However, RPGREx1-19 and RPGRORF15 isoforms have distinct
developmental expression proﬁles in the murine retina. RPGREx1-19
is expressed early in development, declining as photoreceptors
mature and RPGRORF15 expression increases (Wright et al., 2011),
suggesting a speciﬁc function, although there may be redundant
mechanisms ensuring correct photoreceptor development. Zebra-
ﬁsh with an RPGR knockdown fail to develop OS and show systemic
ciliary abnormalities, supporting the view that RPGR is required for
normal retinal development in lower vertebrates (Shu et al., 2010;
Ghosh et al., 2010). Further, the OS of XLPRA2 dogs are misaligned
and fragmented prior to maturation (Beltran et al., 2006), although
this might be secondary to the degeneration process. The role of
RPGR in human retinal development is therefore unclear, but both
vision and retinal structure appear to develop normally in patients
with RPGR mutations. In contrast to its non-essential role during
retinal development, RPGR has an essential function in the main-
tenance of mature photoreceptors.
4. RPGR interactions
A common approach to understanding the function of a protein
is to characterise its interactions. Several RPGR-containing protein
interactions and complexes have been proposed (Fig. 2). The
emerging picture suggests that following its synthesis in the IS,
RPGR is retained at the CC by binding to the RPGR interacting
protein 1 (RPGRIP1), which was identiﬁed by yeast two-hybrid
screening (Boylan and Wright, 2000; Roepman et al., 2000; Honget al., 2001). RPGRIP1 has a coiled coil domain and three C2-like
motifs that are found in many transition zone or CC proteins,
either targeting these proteins to cell membranes or facilitating
their interactions (Remans et al., 2014). The RPGRIP1 C-terminus
RPGR interaction domain forms both homodimers and elongated
ﬁlaments via interactions involving its coiled-coil and C-terminal
domains (Zhao et al., 2003). RPGRIP1 is most strongly expressed in
the CC of photoreceptors (Mavlyutov et al., 2002; Zhao et al., 2003;
Castagnet et al., 2003) but is also present at the centrioles and basal
bodies/transition zone of cultured cells (Shu et al., 2005). RPGRIP1
is essential for the localisation of RPGR to the CC (Zhao et al., 2003;
Patil et al., 2012a; Li, 2014) and has one major retina-speciﬁc iso-
form, RPGRIP1a1, which has been proposed to have a scaffolding
function associated with a proposed “ciliary gate” and entry to the
transition zone and ﬁbres of primary cilia or photoreceptor CC
(Remans et al., 2014). The transition zone contains Y-shaped ﬁbres
linking the axonemal microtubule doublets of the CC with the
overlying plasma membrane, representing part of the proposed
ciliary gate that restricts protein entry and exit to the OS (Reiter
et al., 2012; Sung and Leroux, 2013; Rachel et al., 2012). The
localisation of RPGRIP1 to the CC is in turn dependent on another
ciliary protein, SPATA7, in which mutations result in rhodopsin
mislocalisation to the plasma membrane (8-fold increase), IS (5-
fold increase) and outer nuclear layer. SPATA7 mutations cause
the severe early-onset retinopathy Leber congenital amaurosis
(LCA, type 3) and juvenile RP (Eblimit et al., 2015). Mutations in
RPGRIP1 also cause LCA (type 6) (Dryja et al., 2001; Gerber et al.,
2001) as well as cone-rod dystrophy (CORD13) (Hameed et al.,
2003). A recently generated complete RPGRIP1 KO mouse pro-
duces ‘naked cilia’ which fail to form OS and shows mislocalisation
of rod and cone opsins (although contradicted by Patil et al., 2012b)
as well as other OS proteins, indicating a role both in disc
morphogenesis and OS formation (Won et al., 2009; Patil et al.,
2012b). A partial RPGRIP1 knockout mouse showed disorganised
OS with elongated discs, partially mislocalised rod and cone opsins
and normal CC, but a severe early-onset retinal degeneration also
resembling LCA (Zhao et al., 2003).
RPGR has also been implicated in the trafﬁcking or quality
control of membrane proteinsmoving to/from the OS, since rod and
cone opsins are mislocalised to the IS or plasma membrane in a
variety of CC transport mutants (e.g. kinesin-2, intraﬂagellar
transport or IFT proteins) and RP/LCA mouse models (Bbs2, Ahi1,
Rp1, Rpgrip1, Cep290mice), including several RPGR disease models.
The latter include a naturally occurring Rpgr mutant mouse (rd9;
Thompson et al., 2012), two gene targeted mouse models, namely
Rpgr KO mice (Hong et al., 2000) and RpgrDEx4 mice (Brunner et al.,
2010), XLPRA1 mutant dogs (Zhang et al., 2002) and two human
XLRP carriers with RPGR mutations (Adamian et al., 2006; Aguirre
et al., 2002). Transport of opsin-containing vesicles from Golgi to
the OS minimally requires a rhodopsin C-terminal targeting motif
(VxPx), binding to a dynein motor protein subunit (Tctex-1), vesicle
docking at the base of the CC, and (by analogy with protist cilia)
loading onto IFT complexes (e.g. complex B subunit Ift20) (Keady
et al., 2011). Docking of rhodopsin carrier vesicles probably occurs
at the periciliary membrane complex, a specialised apical mem-
brane microdomain directly facing the CC (Fig. 3). Further transport
to the CC and nascent discs requires (again by analogy with pro-
tists) another IFT complex (e.g. complex A subunit Ift40) and the
kinesin-2 motor (Crouse et al., 2014; Keady et al., 2011). Defects in
transport between the membrane docking and CC delivery steps
should result in rhodopsin accumulation in the OS plasma mem-
brane, as seen in several models (e.g. Spata7/ mutants). In
contrast, mutants that are defective in vesicular transport of opsins
(e.g. BBS proteins, TULP1) show accumulation of vesicles near the
base of the IS while mutants with absent OS (e.g. Rho/ mice)
Fig. 2. The RPGR Interactome. This complex and poorly understood network of cilia proteins has been classiﬁed on the basis of the existing literature, as discussed in this review.
Links between proteins highlight the evidence in the literature for each interaction. The schematic was constructed using the STRING database (http://string-db.org) (Szklarczyk
et al., 2015) and GeneMANIA (http://www.genemania.org/) (Warde-Farley et al., 2010).
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which were found in Rpgrip1, Spata7 or Rpgr KO mice (Hong et al.,
2000;Won et al., 2009). In addition, while opsins weremislocalised
prior to the onset of apoptosis, OS disk or shuttling proteins PRPH2,
ROM-1 and transducin were all correctly localised in the Spata7 KO
mice, arguing for a speciﬁc opsin transport defect in these mice
with presumed abrogation of the Spata7-RPGRIP1-RPGR protein
complex (Eblimit et al., 2015). It has been argued that discrepancies
in observing rhodopsin mislocalization in some animal models ofFig. 3. The Photoreceptor connecting cilium. A modiﬁed sensory cilium, comprising the axon
vertebrate photoreceptors. (a) Microtubule transport facilitates Rhodopsin Transport Carrie
base of the BBs, prior to movement into the CC. The BBs co-ordinate microtubule assemb
backbone and facilitates intra-ﬂagellar transport (IFT) up and down the CC. (c) The CC serves
the outer segment. The CC is therefore crucial for maintenance and survival of the photoreinherited retinal degeneration may be attributed to variability in
the stages of photoreceptor degeneration at the time of analysis.
Indeed, due to the abundance of rhodopsin, its mislocalisation to
the inner segment will inevitably occur once outer segment
degeneration begins, in which case it would be a secondary
consequence rather than a primary cause of disease. However,
several RPGR disease models demonstrate opsin mislocalisation
prior to any discernible photoreceptor degeneration (Hong et al.,
2000; Thompson et al., 2012).eme, connecting cilium (CC) and basal bodies (BB), links the inner and outer segment in
r (RTC) delivery to the pericilliary membrane complex (green dotted line in (b), at the
ly whilst the non-motile axoneme (comprising nine microtubule doublets) acts as a
to compartmentalise the photosensitive pigment rhodopsin into stacks of discs that ﬁll
ceptor. The diagram was modiﬁed from Maerker et al. (2008).
R.D. Megaw et al. / Experimental Eye Research 138 (2015) 32e4136There is indirect molecular evidence linking RPGR functionwith
vesicle trafﬁcking, for example RPGR interactions with RAB8,
whirlin and the cytoskeleton (see below), but since proposed ciliary
gate proteins such as RPGR, RPGRIP1 and CEP290 are all required
for opsin localisation to the OS it is currently more plausible that
this defect is secondary to defective ciliary gate functions.
Recent work has gone some way towards elucidating the
RPGRIP1 interaction with RPGR by showing that the RPGRIP1
interaction domain of RPGR partially overlaps with the domain
interacting with PDEd (PDE6D) (W€atzlich et al., 2013, Remans et al.,
2014) (Fig. 1b), a highly evolutionarily conserved prenyl binding
protein that also binds RPGR (Linari et al., 1999). PDEd interacts
with a variety of prenylated G proteins and phototransduction
proteins (Baehr, 2014). RPGRIP1 may compete with and weaken
PDEd binding to its cargo, following RPGR-mediated PDEd delivery
to the CC, perhaps indicating a cargo delivery or sorting role
(Remans et al., 2014). The 3-dimensional (3-D) structure of the
RPGR RCC1-like domain indicates that it binds PDEd at a highly
sequence-conserved surface patch (Fig. 1b). Binding of PDEd to
cargo proteins is in turn regulated by two unprenylated G proteins,
ARL2 and ARL3, which are involved in cargo release (W€atzlich et al.,
2013). The RP2 gene product greatly accelerates the hydrolysis of
GTP-bound ARL3. RP2 null mutations are therefore thought to
impair the trafﬁcking of prenylated proteins to the photoreceptor
OS (Baehr, 2014). A rare null mutation in the PDE6D gene causes the
ciliopathy Joubert syndrome, associated with retinal dysplasia and
microphthalmia (Thomas et al., 2014). A PDEd knockout mouse
develops a more subtle phenotype with a slowly progressive rod-
cone dystrophy together with mislocalisation of prenylated pho-
totransduction proteins such as rhodopsin kinase (GRK1) and the
catalytic subunits of rod and cone cyclic GMP phosphodiesterase
(PDE6) (Zhang et al., 2007). Non-prenylated proteins such as
rhodopsin were correctly localised to the OS, in contrast to the
situation with RPGR mutations (Zhang et al., 2007). Despite the
apparent phenotypic differences between mouse and human
(whichmay reﬂect mutational differences), the results overall seem
to indicate the involvement of RPGR in multiple trafﬁcking, gate-
keeping and/or cargo delivery steps required for outer segment
function and maintenance.
Another RPGR-interacting protein is CEP290 (NPHP6), which
localises to centrosomes throughout the cell cycle and to the
photoreceptor CC in mouse photoreceptors (Chang et al., 2006). It
was proposed that CEP290 has a role in microtubule nucleation,
centrosome and cilia formation. CEP290 interacts directly with
RPGRORF15 and both proteins form part of a microtubule-associated
protein complex at the centrosome (Chang et al., 2006). Experi-
ments conducted in the model organism Chlamydomonas rein-
hardtii provide compelling evidence that CEP290 is a dynamic
component of the transition ﬁbres and Y-linkers that are thought to
perform a ciliary gate function, since CEP290 mutants alter the
composition of several mainly soluble ﬂagellar proteins (Craige
et al., 2010). RPGR is also mislocalised from the CC to the IS in a
naturally occurring Cep290 mouse mutant (rd16), suggesting that
RPGR is also involved in sorting/loading of speciﬁc IFT and other
protein cargoes at this site (Chang et al., 2006; Craige et al., 2010).
CEP290 has numerous interacting partners (Fig. 2) and CEP290
mutations are associated with retinal degeneration in six partially
overlapping ciliopathy syndromes, consistent with a central role in
ciliary and/or outer segment maintenance (Joubert Syndrome (JBS),
nephronophthisis (NPHP), Leber congenital amaurosis (LCA),
Senior-Loken syndrome (SLS), Meckel-Gruber syndrome (MKS) and
Bardet-Biedl syndrome (BBS) (Sayer et al., 2006)). In summary,
CEP290, RPGR and RPGRIP1 are each associated with ciliary gate
functions that regulate protein trafﬁcking to/from the OS.
RPGR also interacts with Structural Maintenance ofChromosome (SMC) proteins SMC1 and SMC3 (Khanna et al., 2005),
whose functions are thought to include assembly of microtubular
spindle poles during mitosis. The same study also showed that
RPGRORF15 co-immunoprecipitates with a variety of basal body (14-
3-3ε, g-tubulin, IFT88) and both anterograde and retrograde
microtubular transport proteins (kinesin II subunits KIF3A, KAP3
and dynein intermediate and heavy chains, dynactin subunits
DCTN1 and DCTN2), suggesting a role in CC trafﬁcking although
whether as a cargo or a regulator is unclear.
Several members of the nephrocystin family of proteins interact
with RPGR. The nephrocystins are a group of proteins that localise
to primary cilia in kidney and in many cases to photoreceptor CC
(Rachel et al., 2012). They are associated with the renal disease
nephronophthisis (NPHP), a medullary cystic disease. In 10% of
cases, nephrocystins also cause syndromal forms of NPHP with
retinal degeneration (e.g. SLS and JBS). RPGR interacts with the CC
proteins NPHP1 and NPHP4 (Murga-Zamalloa et al., 2010a) in
distinct complexes, as well as with NPHP6 (CEP290) discussed
above. RPGRIP1a is required for the ciliary localisation of NPHP4,
RPGR and another interacting protein, SDCCAG8 (Patil et al., 2012b).
Proteomic analyses suggest the existence of two major complexes
that potentially include RPGR, NPHP1-2-4-8/RPGRIP1L1, and
NPHP2-5-6/CEP290 (Sang et al., 2011). The RPGR-NPHP1/4 binding
sites overlap, so a ‘hand over’ mechanism was proposed, perhaps
facilitating efﬁcient cargo delivery to the CC. Mutations in NPHP5/
IQCB1, encoding an IQ-domain protein which localises to the
photoreceptor CC, cause the ciliopathy SLS. An interaction between
NPHP5 and RPGRORF15 has been demonstrated (Otto et al., 2005)
and the NPHP5 interaction with CEP290 appears crucial for cilio-
genesis (Barbelanne et al., 2013). NPHP5 regulates the multi-
subunit BBSome complex, located at the basal bodies and cen-
triolar satellites, which is thought to be concerned with trafﬁcking
of membrane cargoes to the CC (Barbelanne et al., 2015). In short,
NPHP1, 4, 5, 6 (CEP290) and 8 (RPGRIP1L1) all interact with RPGR,
and while their precise functions are unclear, they appear to in-
ﬂuence the assortment and trafﬁcking of cargoes through the CC to
the OS, as well as through the ciliary transition zone in renal
medullary cells.
The RCC1-like domain of RPGR was initially predicted to act as a
guanine nucleotide exchange factor (GEF) for a Ran-like GTPase
(Meindl et al., 1996). RAB8 is a GTPase that shuttles rhodopsin
transport carriers to the CC base so that its inhibition leads to
mislocalisation of rhodopsin (Moritz et al., 2001). Rabin8 is its
primary GEF (Hattula et al., 2002) but RPGR has also been reported
to activate RAB8 (Murga-Zamalloa et al., 2010b). Human RPGR
mutations perturb this and RPGR knock-down in cells mislocalises
RAB8 away from primary cilia, suggesting that it facilitates RAB8-
led rhodopsin trafﬁcking. However, only one residue required for
RCC1 GEF function is conserved in RPGR (Renault et al., 1998) and
the b-hairpin extension required for GEF activity is not found in
RPGR (W€atzlich et al., 2013), raising questions as to its role in
activating RAB8, so this ﬁnding needs further corroboration.
The RPGR exon ORF15 repeat domain is a hotspot for disease but
its function is unclear. It is predicted to be unstructured and, so far,
interacting partners have not been identiﬁed. In contrast, the basic
C-terminal domain (Fig. 1a) is highly conserved across vertebrates
and binds nucleophosmin (NPM), a protein chaperone (Shu et al.,
2005). The role of this interaction is unknown since, although it
partially co-localises with RPGR at centrosomes during metaphase,
in photoreceptors it localises to the nucleoli. RPGR has been seen in
the nuclei in some cell types but not in photoreceptors (Lu et al.,
2005). Several other ciliary proteins, including CEP290, can also
be found in nuclei, which is perhaps relevant to recent ﬁndings
linking both renal and retinal ciliopathies with DNA damage
response proteins, such as NEK8, ATR, ZNF423 and CEP164, which
R.D. Megaw et al. / Experimental Eye Research 138 (2015) 32e41 37are often located at centrosomes, primary cilia or nuclear DNA
damage foci (Chaki et al., 2012; Choi et al., 2013; Jackson, 2013;
Valdes-Sanchez et al., 2013).
Interestingly, the ORF15 basic domain also interacts with
Whirlin (WHRN), a scaffold protein expressed in cochlear hair cells
and photoreceptors (Wright et al., 2012). WHRN has a role in
cytoskeletal assembly both in inner ear stereocilia (Mburu et al.,
2006; van Wijk et al., 2006) and in photoreceptors, where its
interaction with the actin cross-linking protein espin is important
in regulating the actin ﬁlament network in the periciliary mem-
brane complex, deﬁned by the presence of the proteins usherin,
whirlin or VLGR1 (Peters et al., 1983; Yang et al., 2010) (Fig. 3). An
actin bundle appears to connect the periciliary membrane complex
with the basal body, along which the actin-based motor protein
myosin VIIA appears to travel (Williams et al., 1988; Wang et al.,
2012). N-terminal mutations in WHRN cause Usher syndrome
(type 2D), a syndromic form of RP associated with non-congenital
sensorineural deafness. This links RPGRORF15 to the Usher protein
network, which is in turn thought to directly link the CC with the
periciliary membrane complex, where post-Golgi vesicles are pro-
posed to dock and sort their cargoes (Kremer et al., 2006; Maerker
et al., 2008) (Fig. 3).
The Usher protein network shows clear links to the actin cyto-
skeleton (Kremer et al., 2006) and RPGR knockdown leads to
stronger expression of actin stress ﬁbres (Gakovic et al., 2011). Actin
regulates vesicle trafﬁcking and its polymerisation inhibits cilio-
genesis, whilst depolymerisation doubles cilia length (Kim et al.,
2010) and induces elongated, nascent discs in photoreceptors
(Vaughan and Fisher, 1989) reminiscent of the Rpgrip1 KO mouse
reported by Zhao et al., 2003. Actin is also localised to the distal
portion of the CCwhere discs form (Chaitin and Burnside,1989) and
provides the constricting forces required to facilitate membrane
scission (Kn€odler et al., 2010). RAB8-driven vesicle trafﬁcking oc-
curs along microtubules but also appears to be actin-dependent
(Hattula et al., 2006; Deretic et al., 1995). Increased actin branch-
ing inhibits rhodopsin transport by inhibiting RAB8 activation and
localisation to the OS (Deretic et al., 1995; Moritz et al., 2001). RPGR
may therefore inﬂuence actin regulation of rhodopsin transport
carrier sorting to the CC, disc budding and/or completion of disc
formation.
In summary, RPGR is localized to the photoreceptor CC and to
the corresponding structures (transition zone) in primary cilia, as a
result of its interaction with one or more RPGRIP1 isoforms.
RPGRORF15 functions are likely to be involved in some aspect(s) of
the ciliary gate, and trafﬁcking or sorting of cargoes, some of which
originate from the periciliary membrane complex. Whether this
function is mediated by RPGRIP1, PDEd, nephrocystins, RAB8,
WHRN, the actin or microtubule based cytoskeleton, or a combi-
nation of these, remains to be resolved.
5. Human RPGR disease
Human RPGR disease is a severe form of retinal degeneration,
leaving patients visually impaired at a relatively young age. There is
signiﬁcant phenotypic variability between XLRP patients with
RPGR disease. RCC1-like domain (RLD) mutations tend to cause
more severe disease than ORF15 mutations (Sharon et al., 2003)
and some are also implicated in systemic ciliary disease. RLD mu-
tations have been subdivided on the basis of their location in the
protein and effects on function into six classes (Patil et al., 2012a).
The classes considered RPGR protein folding, stability and in-
teractions with RPGRIP1a1 or PDEd. More recently, high-resolution
3-D structural data for the RPGR RCC1-like domain in complex with
PDEd (W€atzlich et al., 2013) and RPGRIP1 (Remans et al., 2014) was
determined by crystallography. These structures revealed thatpreviously described missense mutations were not located at the
binding site in the case of RPGR-PDEd, and likewise those muta-
tions located in the vicinity of the RPGR-RPGRIP1 binding site did
not perturb this interaction when tested biochemically. Several
known patient missense mutations were however likely to impact
on the structural integrity of the beta-propeller fold (W€atzlich et al.,
2013).
Clinical diagnoses in RPGR disease vary between classical XLRP
(95%), cone dystrophy, cone-rod dystrophy or atrophic macular
degeneration (3%) and ciliopathy (2%) (Dry et al., 1999; Zito et al.,
2003; Iannaccone et al., 2003; Shu et al., 2007). Further, dizygotic
twins with a single nucleotide deletion in ORF15 (1339delA) were
shown to be discordant for disease severity (Walia et al., 2008) and
large families can display marked phenotypic variability (Fahim
et al., 2011; Huang et al., 2012). In addition to varying degrees of
residual activity, clinical variability may be due to environmental
inﬂuences, stochastic developmental effects and genetic back-
ground (epistasis), where RPGRmutations are affected by 'modiﬁer
genes.' Recently a SNP screen of RPGR patients displaying varying
disease severity showed that SNPs in IQCB1 and RPGRIP1L were
associated with disease severity (Fahim et al., 2011). Until XLRP
patients have their whole genome routinely sequenced it will be
hard to evaluate whether such disease modiﬁers are present, which
could inﬂuence prognosis or patient selection for trials of emerging
therapies (see below).
Several studies have examined RPGR disease progression.
Genotype-phenotype concordance has been demonstrated
regarding electrophysiology (rod-cone versus cone-rod dystrophy)
and ﬁeld loss patterns (Zahid et al., 2013). Interestingly, 30-end
ORF15 mutations cause cone-rod disease on ERG analysis, indi-
cating relative sparing of rods (Sharon et al., 2003; Zahid et al.,
2013). Analysis of disease progression over time showed a steady
deterioration in visual acuity and ﬁelds (Huang et al., 2012) with
two main ﬁeld loss patterns; most commonly, a mid-peripheral
scotoma separating a preserved central cone island from a region
of preserved peripheral rod function and, less commonly, a para-
central loss leaving small central islands of cone function which
could be maintained until late in disease. In teenage patients, rod
function varied from normal to profound loss but deteriorated
steadily thereafter. Cone dysfunction was milder and showed less
variability. Female RPGR carriers are generally asymptomatic but
can display clinical abnormalities with tapetal reﬂexes, peripheral
retinal thinning and severe rod and cone dysfunction (Bird, 1975;
Acton et al., 2013). This highlights the importance of examining
female relatives, particularly regarding genetic counselling.
6. Models of RPGR disease
6.1. Animal models
Various RPGR disease models have been studied. RPGR knock-
down in ciliated cell lines is one approach that has helped to un-
ravel disease mechanisms (e.g. Gakovic et al., 2011). Animal models
have also been used. In the original Rpgr KO mouse, the retina
developed normally but showed degenerative changes by 2months
(Hong et al., 2000). Cone opsins (but not rhodopsin) were mis-
localised at an early stage. By 6.5 months, photoreceptor function
was compromised and discs appeared disorganised despite a
normal CC, suggesting trafﬁcking and/or disc membrane formation
abnormalities. This relatively mild phenotype resembles late-onset
cone-rod degeneration and subsequent analysis reported residual
RPGRORF15 expression (Khanna et al., 2005). A recent Rpgr exon1
conditional knockout mouse on a different (BALB/c) genetic back-
ground showed a faster rate of retinal degeneration and visual loss
than the Rpgr KO mouse (Huang et al., 2012). A naturally occurring
R.D. Megaw et al. / Experimental Eye Research 138 (2015) 32e4138rd9 mouse was found to have a 32-bp duplication in ORF15, pro-
ducing a much slower degeneration (Thompson et al., 2012).
Different strains of mice sharing the same RPGR mutation can ex-
press a different phenotype, highlighting the role of genetic back-
ground effects (Brunner et al., 2010). RpgrORF15 overexpression
partially rescues the Rpgr KO mouse, suggesting a loss-of-function
effect of the protein (Hong et al., 2005). However, overexpression
of a truncated murine-speciﬁc ORF15 variant led to more rapid
degeneration compared to the KO alone, on both wild-type and
Rpgr-null backgrounds (Hong et al., 2004), suggesting a gain-of-
function (GOF) role for this particular variant. A GOF phenotype is
difﬁcult to reconcile with clinical disease, since most female car-
riers remain asymptomatic. Carrier females are usually protected
by X chromosome inactivation and/or cell autonomous mutational
effects but the substantial rescue of the Rpgr KO mouse and XLPRA
dogs (see below) by gene augmentation therapy also argues against
signiﬁcant GOF mutations in XLRP patients.
Two naturally occurring RPGR disease models exist in dogs.
Canine X-linked progressive retinal atrophy (XLPRA) occurs in the
Siberian Samoyed husky (XLPRA1; 5-bp deletion in exon ORF15)
and in a mixed breed dog (XLPRA2; 2-bp deletion in exon ORF15).
The XLPRA1 mutation allows normal photoreceptor development
and function until 6 months of age followed by a slow degeneration
of rods, which die by apoptosis. The XLPRA2 phenotype is severe,
with abnormal retinal development leading to disorganised OS and
rapid degeneration (Zeiss et al., 1999; Zhang et al., 2002; Beltran
et al., 2006). These dogs are excellent large animal models and
provide a stepping-stone towards clinical trials for novel therapies
(see below). Finally, a zebraﬁsh knockdown model of RPGR disease
has been reported to show ciliary abnormalities (Shu et al., 2010).
Animal models have drawbacks, not the least of which is their cost.
Alternative technologies to supplement these models may there-
fore be useful.
6.2. iPSC technology and three-dimensional retinal culture
The prospect of reprogramming terminally-differentiated so-
matic cells from adult tissue into pluripotent cells was demon-
strated in principle by the cloning of tadpoles and sheep (Gurdon,
1962; Wilmut et al., 1997) and has been realised in humans
(Takahashi et al., 2007). These induced pluripotent stem cells
(iPSCs) can be derived from any genetic background, including
patients with RPGR disease, so ‘disease-in-a-dish’ modelling is
possible if mature photoreceptors can be derived from iPSCs.
Major progress has beenmade in pattering stem cells to produce
post-mitotic photoreceptors. Exogenous molecules promote such
conversion by means of many published protocols (Lamba et al.,
2006; Osakada et al., 2008; Mellough et al., 2012). Initially these
protocols encouraged two-dimensional culture, but recent under-
standing of the importance of the extracellular matrix in recapit-
ulating endogenous signalling required for human retinal
development (Nakano et al., 2012) has led biologists to replace 2D
modelling with 3D protocols, with improved results. Floating
aggregate cultures facilitate organised, stratiﬁed neuroretina pro-
duction with light-sensitive photoreceptors being generated
(Zhong et al., 2014). These cultures provide an excellent model of
RPGR disease.
7. Future treatment options
7.1. Gene therapy
Gene augmentation therapy appears a feasible, safe treatment
strategy for at least some inherited retinal dystrophies (Bainbridge
et al., 2008; Maguire et al., 2008; Cideciyan, 2010; Jacobson et al.,2012). Recently, there was progress towards RPGR gene augmen-
tation therapy when an adeno-associated virus 2/5 vector (pack-
aging restriction< 4.7 kb) mediated the transfer of full-length
human RPGRORF15 (driven by the human IRBP promoter) into pho-
toreceptors, preventing degeneration in both canine RPGR disease
models and resulting in increased numbers of photoreceptors,
preserved structure and absence of rhodopsin and L/M cone opsin
mislocalization (Beltran et al., 2012). Reduced Muller cell reactivity
in treated eyes also indicated that the harmful retinal remodelling
found in this disease was also reduced. However, with RPE65-LCA
patients, gene therapy could not prevent retinal degeneration
progressing over a three year period despite substantial visual
improvement at ﬁrst (Cideciyan et al., 2013). Similarly with the
canine model of RPGR disease, degeneration continued unless
treatment was initiated prior to photoreceptor loss (Cideciyan et al.,
2013). Improvement in visual function therefore cannot be
assumed to imply protection from degeneration, suggesting the
need for a combinatorial approach in treating retinal dystrophies.
Further caution comes from the ﬁnding that overexpression of
RpgrEx1-19 (but not RpgrORF15) on an Rpgr null background led to a
more severe phenotype than in the Rpgr null mouse (Wright et al.,
2011). While over-expressing wildtype RpgrORF15 is better tolerated,
this may still cause problems by altering Rpgr isoform ratios.
Overexpression of a genomic fragment containing the entire mouse
Rpgr gene resulted in ﬂagellar defects and male infertility, with a
severity correlating with Rpgr copy number (Brunner et al., 2008).
Rpgr co-localisedwith acetylated a-tubulin inmouse sperm ﬂagella
(Khanna et al., 2005). These results suggest the need for careful
control of RPGR expression levels.
7.2. Cell replacement therapy
Advances in stem cell-derived retinal differentiation has led to
the possibility of photoreceptor precursor transplant into diseased
eyes. Embryonic stem cell (ESC)-derived retinal pigment epithe-
lium (RPE) for cell replacement in RPE dystrophies is already in
clinical trials and appears to be safe (Schwartz et al., 2015). The
optimumdevelopmental stage of photoreceptor progenitor cells for
transplantation has been established (MacLaren et al., 2006) and
the procedure has led to improvement of vision in blind mice
(Pearson et al., 2012; Barber et al., 2013; Singh et al., 2013).
Photoreceptor progenitor cells derived from three-dimensional ESC
cultures can also integrate into rodent retina (Gonzalez-Cordero
et al., 2013). However, whilst cell replacement may be a viable
treatment option for retinal dystrophies in the future, the extent of
rod loss experienced in RPGR disease raises questions as to whether
sufﬁcient numbers of rod progenitors can integrate into the retina
to make an impact on visual loss.
8. Conclusion
RPGR mutations are responsible for 10e20% of all RP patients
and cause severe disease for which there is no treatment. This re-
view has sought to summarise current understanding of RPGR
biology, including proposed roles in the ciliary gate that regulates
protein trafﬁcking to and from the photoreceptor OS. The results of
treating animal models of RPGR disease show considerable promise
and suggest that gene replacement therapy and, in the future, cell
replacement therapy, could lead to improved visual function in this
disorder.
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